Summary of Phase 1 Zoldonrasib Data at AACR 2026 ( Abstract # CT021 ) ...
Zai Lab Limited (NASDAQ:ZLAB) is one of the 10 Overlooked Growth Stocks to Buy Now. Zai Lab Limited (NASDAQ:ZLAB) is one of ...
Early results presented at a cancer research conference showed tumor shrinkage and slowed disease progression in patients who ...
Revolution Medicine has wowed investors and analysts by announcing dazzling data from its Phase III RASolute 302 trial ...
The incidence and mortality rate of esophageal cancer in China fell by around 4.5 percent annually, according to the figures ...
A Cell Perspective argues that generative AI models could help tackle cancer’s multiscale, multimodal complexity by ...
Arschang Valipour, head of Internal Medicine and Pulmonology at the Floridsdorf Clinic, presented a bronchoscopy robot this ...
How does preventing cirrhosis lower the risk of liver cancer mortality? Early intervention, viral hepatitis treatment, and ...
CStone Pharmaceuticals ("CStone," HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, immunology, inflammation, and other key ...
Morning Overview on MSN
Revolution Medicines trial points to longer survival in pancreatic cancer
For more than two decades, oncologists treating advanced pancreatic cancer have watched new drugs fail to move the survival ...
Australia’s most revered medical researchers are crying out for funding to cure deadly diseases while taxpayers fork out more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results